Literature DB >> 9551030

Physician specialty is associated with differences in warfarin use for atrial fibrillation.

J C Kellen1, M L Russell.   

Abstract

OBJECTIVE: To determine whether physician specialty is associated with prescription of warfarin to elderly persons with atrial fibrillation.
DESIGN: Cross-sectional survey.
SETTING: One hundred and thirty-eight randomly selected general practitioners--all 58 internists and all 27 cardiologists in southern Alberta were surveyed by mail. INTERVENTION: Physicians identified their preferred drug for stroke prevention generally and in response to two hypothetical cases. MAIN
RESULTS: Response rates were 66% (general practitioners), 76% (internists) and 89% (cardiologists). Specialists (92%) were more likely than general practitioners (76%) to choose warfarin (P = 0.007). Findings were similar for questions related to case scenarios; however, the magnitude of differences between specialists and general practitioners was less pronounced. Specialists were more likely (77%) to prescribe warfarin for elderly females than were general practitioners (62%, P = 0.08). Similar proportions of specialists (77%) and general practitioners (67%) would prescribe warfarin to elderly males.
CONCLUSION: Physician specialty is associated with warfarin prescription for elderly persons with atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551030

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  [Oral anticoagulation treatment in patients with non-valvular auricular fibrillation].

Authors:  E Arrojo Arias; G Mora Navarro; A Abón Santos; M S Araujo Luis; C Capdevila Gallego; M J Gutiérrez Torres
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

2.  Medical speciality and pattern of medicines prescription.

Authors:  A Vallano; E Montané; J M Arnau; X Vidal; C Pallarés; M Coll; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2004-10-16       Impact factor: 2.953

3.  Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.

Authors:  Niteesh K Choudhry; Geoffrey M Anderson; Andreas Laupacis; Dennis Ross-Degnan; Sharon-Lise T Normand; Stephen B Soumerai
Journal:  BMJ       Date:  2006-01-10

4.  Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.

Authors:  Anne Holbrook; Renée Labiris; Charles H Goldsmith; Kaede Ota; Sandra Harb; Rolf J Sebaldt
Journal:  CMAJ       Date:  2007-05-22       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.